title: Etiology of OHSS and use of dopamine agonists.
abstract: Vascular endothelial growth factor is the factor that causes increased capillary permeability and therefore the most serious manifestations of ovarian hyperstimulation syndrome. Dopamine agonists can both prevent and treat ovarian hyperstimulation syndrome by blocking expression of the vascular endothelial growth factor receptor.
authors.affiliation: Instituto Valenciano de Infertilidad, IVI-Lisboa, Lisbon, Portugal. sergio.soares@ivi.es
authors.forename: Sérgio Reis
authors.initials: SR
authors.lastname: Soares
mesh_terms: D000818:Animals; D018491:Dopamine Agonists / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D005300:Fertility Agents, Female / Q000009:adverse effects*; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control*; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism; D010060:Ovulation / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D040262:Receptors, Vascular Endothelial Growth Factor / Q000187:drug effects / Q000378:metabolism; D018570:Risk Assessment; D012307:Risk Factors; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D018491:Dopamine Agonists; D005300:Fertility Agents, Female; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor